Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 11

Zeitschriftenartikel

Bornhäuser, Martin; Schliemann, Christoph; Schetelig, Johannes; Röllig, Christoph; Kramer, Michael; Glass, Bertram; Platzbecker, Uwe; Burchert, Andreas; Hänel, Mathias; Müller, Lutz P.; Klein, Stefan; Bug, Gesine; Beelen, Dietrich; Rösler, Wolf; Schäfer-Eckart, Kerstin; Schmid, Christoph; Jost, Edgar; Lenz, Georg; Tischer, Johanna; Spiekermann, Karsten ORCID logoORCID: https://orcid.org/0000-0002-5139-4957; Pfirrmann, Markus ORCID logoORCID: https://orcid.org/0000-0002-8948-0690; Serve, Hubert; Stölzel, Friedrich; Alakel, Nael; Middeke, Jan Moritz; Thiede, Christian; Ehninger, Gerhard; Berdel, Wolfgang E. und Stelljes, Matthias (2023): Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia. In: JAMA Oncology, Bd. 9, Nr. 4: S. 519-526

Isfort, Susanne ORCID logoORCID: https://orcid.org/0000-0002-2855-561X; Manz, Kirsi ORCID logoORCID: https://orcid.org/0000-0002-7740-4076; Teichmann, Lino L.; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R.; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus ORCID logoORCID: https://orcid.org/0000-0002-8948-0690; Wolf, Dominik und Brümmendorf, Tim H. (2023): Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study. In: Annals of Hematology, Bd. 102: S. 2741-2752 [PDF, 1MB]

Machova Polakova, Katerina ORCID logoORCID: https://orcid.org/0000-0002-7398-5555; Albeer, Ali ORCID logoORCID: https://orcid.org/0009-0002-1746-1260; Polivkova, Vaclava; Krutska, Monika; Vlcanova, Katerina; Curik, Nikola; Fabarius, Alice; Klamova, Hana; Spiess, Birgit; Waller, Cornelius F. ORCID logoORCID: https://orcid.org/0000-0002-5777-0212; Brümmendorf, Tim H. ORCID logoORCID: https://orcid.org/0000-0002-9677-3723; Dengler, Jolanta; Kunzmann, Volker; Burchert, Andreas ORCID logoORCID: https://orcid.org/0000-0002-8411-8844; Belohlavkova, Petra; Mustjoki, Satu ORCID logoORCID: https://orcid.org/0000-0002-0816-8241; Faber, Edgar; Mayer, Jiri ORCID logoORCID: https://orcid.org/0000-0003-0567-9887; Zackova, Daniela ORCID logoORCID: https://orcid.org/0000-0001-9802-8148; Panayiotidis, Panayiotis; Richter, Johan ORCID logoORCID: https://orcid.org/0000-0002-0374-6823; Hjorth-Hansen, Henrik ORCID logoORCID: https://orcid.org/0000-0002-2670-5696; Kamińska, Magdalena; Płonka, Magdalena; Szczepanek, Elżbieta; Szarejko, Monika; Bober, Grażyna; Hus, Iwona; Grzybowska-Izydorczyk, Olga; Wasilewska, Ewa; Paczkowska, Edyta ORCID logoORCID: https://orcid.org/0000-0001-7052-9741; Niesiobędzka-Krężel, Joanna; Giannopoulos, Krzysztof; Mahon, Francois X.; Sacha, Tomasz ORCID logoORCID: https://orcid.org/0000-0002-7207-6595; Saußele, Susanne ORCID logoORCID: https://orcid.org/0000-0003-0357-5785 und Pfirrmann, Markus ORCID logoORCID: https://orcid.org/0000-0002-8948-0690 (2023): The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. In: Leukemia, Bd. 38: S. 318-325 [PDF, 1MB]

Schönfeld, Lioba; Rinke, Jenny; Hinze, Anna; Nagel, Saskia N.; Schäfer, Vivien; Schenk, Thomas; Fabisch, Christian; Brümmendorf, Tim H. ORCID logoORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID logoORCID: https://orcid.org/0000-0002-8411-8844; Coutre, Philipp le; Krause, Stefan W. ORCID logoORCID: https://orcid.org/0000-0002-5259-4651; Saussele, Susanne ORCID logoORCID: https://orcid.org/0000-0003-0357-5785; Safizadeh, Fatemeh; Pfirrmann, Markus ORCID logoORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas ORCID logoORCID: https://orcid.org/0000-0003-0626-0834 und Ernst, Thomas ORCID logoORCID: https://orcid.org/0000-0003-2147-489X (2022): ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. In: Leukemia, Bd. 36: S. 2242-2249 [PDF, 1MB]

Schwaab, Juliana; Naumann, Nicole; Luebke, Johannes; Jawhar, Mohamad; Somervaille, Tim C. P.; Williams, Mark S.; Frewin, Rebecca; Jost, Philipp J.; Lichtenegger, Felix S.; La Rosee, Paul; Storch, Nicola; Haferlach, Torsten; Horny, Hans-Peter; Fabarius, Alice; Haferlach, Claudia; Burchert, Andreas; Hofmann, Wolf-Karsten; Cross, Nicholas C. P.; Hochhaus, Andreas; Reiter, Andreas und Metzgeroth, Georgia (2020): Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. In: American Journal of Hematology, Bd. 95, Nr. 7: S. 824-833

Burchert, Andreas; Bug, Gesine; Fritz, Lea V.; Finke, Jürgen; Stelljes, Matthias; Roellig, Christoph; Wollmer, Ellen; Waesch, Ralph; Bornhaeuser, Martin; Berg, Tobias; Lang, Fabian; Ehninger, Gerhard; Serve, Hubert; Zeiser, Robert; Wagner, Eva-Maria; Kroeger, Nicolaus; Wolschke, Christine; Schleuning, Michael; Goetze, Katharina S.; Schmid, Christoph; Crysandt, Martina; Esseling, Eva; Wolf, Dominik; Wang, Ying; Boehm, Alexandra; Thiede, Christian; Haferlach, Torsten; Michel, Christian; Bethge, Wolfgang; Wuendisch, Thomas; Brandts, Christian; Harnisch, Susanne; Wittenberg, Michael; Hoeffkes, Heinz-Gert; Rospleszcz, Susanne; Burchardt, Alexander; Neubauer, Andreas; Brugger, Markus; Strauch, Konstantin; Schade-Brittinger, Carmen und Metzelder, Stephan K. (2020): Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN). In: Journal of Clinical Oncology, Bd. 38, Nr. 26

Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Alice and Haferlach und Pfirrmann, Markus (2019): Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. In: Haematologica, Bd. 104, Nr. 5: S. 955-962

Budau, Laura; Wilhelm, Christian; Moll, Roland; Jaekel, Jörg; Hirt, Carsten; Doelken, Gottfried; Maschmeyer, Georg; Neubauer, Ellen; Strauch, Konstantin; Burchert, Andreas; Herold, Michael und Neubauer, Andreas (2019): Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial. In: Journal of Cancer Research and Clinical Oncology, Bd. 145, Nr. 8: S. 2149-2156

Solovey, Maria; Wang, Ying; Michel, Christian; Metzeler, Klaus H.; Herold, Tobias; Goethert, Joachim R.; Ellenrieder, Volker; Hessmann, Elisabeth; Gattenloehner, Stefan; Neubauer, Andreas; Pavlinic, Dinko; Benes, Vladimir; Rupp, Oliver und Burchert, Andreas (2019): Nuclear factor of activated T-cells, NFATC1, governs FLT3(ITD)-driven hematopoietic stem cell transformation and a poor prognosis in AML. In: Journal of Hematology & Oncology, Bd. 12, 72

Rinaldetti, Sébastien; Pfirrmann, Markus; Manz, Kirsi ORCID logoORCID: https://orcid.org/0000-0002-7740-4076; Guilhot, Joelle; Dietz, Christian; Panagiotidis, Panayiotidis; Spiess, Birgit; Seifarth, Wolfgang; Fabarius, Alice; Müller, Martin; Pagoni, Maria; Dimou, Maria; Dengler, Jolanta; Waller, Cornelius F.; Brümmendorf, Tim H.; Herbst, Regina; Burchert, Andreas; Janßen, Carsten; Goebeler, Maria Elisabeth; Jost, Philipp J.; Hanzel, Stefan; Schafhausen, Philippe; Prange-Krex, Gabriele; Illmer, Thomas; Janzen, Viktor; Klausmann, Martine; Eckert, Robert; Büschel, Gerd; Kiani, Alexander; Hofmann, Wolf-Karsten; Mahon, François-Xavier und Saussele, Susanne (April 2018): Effect of ABCG2, OCT1, and ABCB1(MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial. In: Clinical Lymphoma, Myeloma & Leukemia, Bd. 18, Nr. 4: S. 266-271 [PDF, 462kB]

Bartsch, Detlef K.; Gercke, Norman; Strauch, Konstantin; Wieboldt, Ronja; Matthaei, Elvira; Wagner, Vinona; Rospleszcz, Susanne; Schaefer, Agnes; Franke, Frederike S.; Mintziras, Ioannis; Bauer, Christian; Grote, Tobias; Figiel, Jens; Di Fazio, Pietro; Burchert, Andreas; Reinartz, Silke; Pogge von Strandmann, Elke; Kloeppel, Guenter und Slater, Emily P. (2018): The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. In: Journal of Clinical Medicine, Bd. 7, Nr. 10, 295 [PDF, 476kB]

Diese Liste wurde am Sat Mar 23 22:14:22 2024 CET erstellt.